Immunology

Leading cancer research and clinical trials

Immune System Research

Our immunology program focuses on autoimmune diseases, inflammatory conditions, and immune-mediated disorders. We conduct trials for novel biologics and immunomodulatory therapies.

Therapeutic Focus

Rheumatoid arthritis studies
Inflammatory bowel disease trials
Psoriasis and psoriatic arthritis
Systemic lupus erythematosus
Transplant immunology
Allergy and asthma research

Foundational Technologies & Key Targets

Molecular Targets

TNF-alpha: Tumor necrosis factor-alpha, a key inflammatory cytokine targeted by biologics for rheumatoid arthritis and IBD.

IL-17 & IL-23: Interleukins central to inflammatory pathways, particularly effective targets for psoriasis and psoriatic arthritis.

JAK-STAT Pathway: Janus kinase-signal transducer and activator of transcription pathway, targeted by small molecule inhibitors for multiple inflammatory conditions.

Therapeutic Approaches

Biologics: Large-molecule therapies including TNF inhibitors (infliximab, adalimumab), IL-17 inhibitors (secukinumab), and IL-23 inhibitors (guselkumab) that specifically target inflammatory cytokines. JAK Inhibitors: Small molecule drugs that block the JAK-STAT pathway to reduce inflammation. Monoclonal Antibodies (mAbs): Engineered antibodies targeting specific immune system components.

Cell Therapy Applications

CAR-T for Autoimmune Diseases: Emerging therapy being tested for severe lupus and other autoimmune conditions by resetting the immune system through targeted B-cell depletion. Regulatory T-cell (Treg) Therapy: Expanding and reinfusing regulatory T-cells to restore immune tolerance in autoimmune disorders and transplant rejection.

Advanced Immunology

We utilize cutting-edge immunological assays, flow cytometry, and biomarker analysis to characterize immune responses and evaluate therapeutic mechanisms of action.

Integrated Research Excellence

Immunology studies benefit from our deeply integrated service ecosystem. Clinical Trials Management orchestrates complex biologic trials with specialized immunological monitoring protocols. Data Management manages intricate immunoassay data and flow cytometry results with precision, while Biostatistics employs advanced techniques for biomarker-driven analysis. Quality Assurance maintains stringent oversight of biological sample handling and laboratory procedures. Regulatory Affairs expertly navigates biologic licensing pathways, and Medical Writing articulates complex immunological mechanisms in regulatory submissions.